Figure 5From: Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab Blood cell counts after 227 Th-trastuzumab therapy. Assessment of bone marrow toxicity estimated by white blood cell counts (a) and platelet counts (b) as a function of time after administration of NaCl, cold trastuzumab, and 200, 400, and 600 kBq/kg of 227Th-trastuzumab. Line graphs shows means of each treatment group.Back to article page